Gadoxetic acid is a liver-specific contrast agent and has been reported to be useful for the detection of liver metastases in patients with pancreatic ductal adenocarcinoma (PDAC). Recently, aberrant OATP expression has been reported in liver metastases from PDAC and is associated with poor prognosis. Our results show that patients with liver metastases demonstrating heterogeneous hypointensity on hepatobiliary phase images are associated with worse overall survival compared to those with homogeneous hypointensity.
This abstract and the presentation materials are available to members only; a login is required.